Alphatec Holdings, Inc.
ATEC Healthcare Medical Devices
Alphatec Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $764.2 million, up 25.0% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 40.7%, free cash flow fell 146.9% and total debt fell 7.79%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
Follow ATEC
Alphatec Holdings, Inc. (ATEC) Altman Z-score
Alphatec Holdings, Inc.'s Altman Z-score for fiscal 2025 is 0.89, in the distress zone (below 1.81).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 0.89 | 1.58 |
| FY2024 | −0.70 | (0.59) |
| FY2023 | −0.11 | 1.01 |
| FY2022 | −1.12 | (0.71) |
| FY2021 | −0.41 | (1.82) |
| FY2020 | 1.42 | 4.00 |
| FY2019 | −2.59 | 1.86 |
| FY2018 | −4.44 | 1.60 |
| FY2017 | −6.04 | (0.52) |
| FY2016 | −5.52 | 1.71 |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.29 | — | 0.35 | |
| Retained earnings / total assets | (1.80) | — | −2.52 | |
| EBIT / total assets | (0.10) | — | −0.34 | |
| Market value of equity / total liabilities | 4.05 | — | 2.43 | |
| Sales / total assets | 0.97 | — | 0.97 | |
| Altman Z-score | Distress zone | 0.89 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −4.63 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| INSP Inspire Medical Systems, Inc. compare | 14.5× |
| AXGN AxoGen, Inc. compare | 9.2× |
| UFPT UFP Technologies, Inc. compare | 6.9× |
| ESTA Establishment Labs Holdings Inc. compare | 2.7× |
| CNMD CONMED Corporation compare | 1.9× |
| BFLY Butterfly Network, Inc. compare | 1.6× |
| BVS Bioventus Inc. compare | 1.3× |
| ATEC Alphatec Holdings, Inc. | 0.9× |
| NVCR NovoCure Limited compare | 0.4× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets